Publications & Resources

MLMIC announces an important clarification on where to send the designation by an eligible policyholder for a policy administrator or EPLIP employer to receive cash consideration upon approval of the proposed transaction with Berkshire Hathaway.

MLMIC is pleased to report that it has prepared and distributed a Policyholder Information Statement to Record Date Policyholders with detailed information about the proposed conversion and acquisition by National Indemnity Company, a subsidiary of Berkshire Hathaway Inc.

A public hearing has been scheduled by the NYS Superintendent of Financial Services to consider the Plan of Conversion adopted by MLMIC’s Board of Directors.

We are pleased to report the latest progress on the sponsored demutualization transaction with National Indemnity Company (the Sponsor), a subsidiary of Berkshire Hathaway Inc. (BHI).

MLMIC’s Q1 financials show a strong start to 2018 for New York’s leading medical liability insurer. In a consistently challenging insurance marketplace, it is reassuring to know that MLMIC is sound and ready to serve its policyholders.

MLMIC will be sending Section 18 excess insurance renewal notices to policyholders May 1. Renewal applications are due prior to July 1 and may be submitted through MLMIC’s secure policyholder portal. Excess insurance provides an important layer of insurance protection to policyholders.

The Healthcare Association of New York State (HANYS) and MLMIC are collaborating to conduct an in-depth analysis of claims data. This effort will explore potential linkages between patient safety protocols, patient health outcomes and adverse events.

New York is among only three states with total medical malpractice payouts exceeding $300 million in 2017. In addition, its total payout of $617,973,000 earns it the distinction as the state with the highest per capita payout ($313) in the nation.

As noted in our 2017 Annual Report, MLMIC continues to put policyholders first in a fiscally responsible and diligent manner. As a result, the Company is well positioned to respond to both the challenges and opportunities that come with New York’s medical malpractice insurance environment

ACOG District II – MLMIC partnership will help both expand their ability to improve patient safety and reduce risk in select focus areas, such as maternal mortality and morbidity.